BTBD12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.48430000512789E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.30340000015217E-07 |
Normal-vs-Stage2 |
1.283940E-03 |
Normal-vs-Stage3 |
1.00370000000183E-06 |
Normal-vs-Stage4 |
4.48929999999903E-05 |
Stage1-vs-Stage2 |
7.645200E-01 |
Stage1-vs-Stage3 |
7.458600E-01 |
Stage1-vs-Stage4 |
9.099600E-01 |
Stage2-vs-Stage3 |
6.164800E-01 |
Stage2-vs-Stage4 |
8.556600E-01 |
Stage3-vs-Stage4 |
7.169200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.20960000016268E-07 |
Normal-vs-AfricanAmerican |
2.9997999999587E-06 |
Normal-vs-Asian |
9.65109999999658E-05 |
Caucasian-vs-AfricanAmerican |
3.423800E-02 |
Caucasian-vs-Asian |
8.926200E-02 |
AfricanAmerican-vs-Asian |
4.806400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.50990000000484E-06 |
Normal-vs-Female |
3.95870003444543E-11 |
Male-vs-Female |
8.164700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.715300E-03 |
Normal-vs-Age(41-60Yrs) |
2.54660004195273E-09 |
Normal-vs-Age(61-80Yrs) |
1.77320000005476E-06 |
Normal-vs-Age(81-100Yrs) |
7.088400E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.531800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.489200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.848000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.580040E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.322830E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.360000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.62650000029774E-07 |
Normal-vs-Grade 2 |
1.78549999996225E-06 |
Normal-vs-Grade 3 |
6.19759999986869E-07 |
Normal-vs-Grade 4 |
2.02029999996078E-06 |
Grade 1-vs-Grade 2 |
2.361800E-02 |
Grade 1-vs-Grade 3 |
1.400220E-02 |
Grade 1-vs-Grade 4 |
4.987700E-02 |
Grade 2-vs-Grade 3 |
8.757400E-01 |
Grade 2-vs-Grade 4 |
3.517000E-01 |
Grade 3-vs-Grade 4 |
3.758600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.358890E-04 |
Normal-vs-ccB subtype |
4.39759995085609E-09 |
ccA subtype-vs-ccB subtype |
9.983300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.1802999950491E-08 |
Normal-vs-N1 |
1.756360E-02 |
N0-vs-N1 |
7.212000E-01 |
|
|